InsidersTradesSigma
Follow the メディキット株式会社 stock price and the full management transaction log of the company, a listed equity based in Japan. Shares trade on the JP market, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, メディキット株式会社 has published 7 insider filings. Market capitalisation: €41bn. The latest transaction was disclosed on 23 July 2026 (Holding update). Among the most active insiders: Fidelity Management & Research Company LLC. The full history is free.
7
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
10Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,915 of 29,055 companies
71.0
score / 100
Value72
Quality70
FCF yld3.0%
Earn yld7.2%
EV/EBITDA6.4x
ROE6.9%
Gross mgn38%
Net mgn13%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 23 July 2026
Declarations7 total
ShareXTKSEDINET:S100Y9YY
ShareXTKSEDINET:S100Y9BZ
100.0% of flowShareXTKSEDINET:S100QR4U
100.0% of flowShareXTKSEDINET:S100QQL2
7 of 7 declarations
关于 メディキット株式会社
Medikit 是一家在 XTKS 市场上市的医疗保健和制药领域的公司。它专注于医疗和制药产品的制造和分销。